))
Investigating the signals in primary care prescribing before a diagnosis of bladder or renal cancer
Manage episode 388978900 series 3310902
Content provided by The British Journal of General Practice. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The British Journal of General Practice or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode, we talk to Dr Garth Funston, who is a Clinical Senior Lecturer in Primary Care Cancer Research within the Wolfson Institute of Population Health at Queen Mary University of London.
Title of paper: Pre-diagnostic prescription patterns in bladder and renal cancer: a longitudinal linked data study
Available at: https://doi.org/10.3399/BJGP.2023.0122
Previous studies have demonstrated that prescription rates for certain medications increase many months before the diagnosis of some cancers. Determining whether prescribing for common urological clinical features increases in patients with renal and bladder cancer could help us identify opportunities for more timely diagnosis. We found that prescription rates for UTI medications increased 9 months before bladder and renal cancer diagnosis, with an even earlier increase occurring before bladder cancer diagnosis in women (11 months). This indicates that there is a window of opportunity in which investigation and referral could lead to earlier cancer detection in some patients presenting to their GP with features of UTI.
180 episodes
Share
